Literature DB >> 26775559

Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Gregory Thomas Brown1, David E Kleiner2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the liver injury most often associated with disorders of insulin resistance, including obesity, diabetes and the metabolic syndrome. The term encompasses several patterns of liver injury, including a relatively benign condition of steatosis without hepatocellular injury, nonalcoholic steatohepatitis (NASH), and a pattern of zone 1 steatosis, inflammation and fibrosis mainly observed in prepubertal children. Staging and grading systems have been developed to characterize the histological changes in NAFLD, mainly as a tool for clinical research. The histological features of NAFLD across these different manifestations and the scoring systems used to evaluate disease severity are discussed. Published by Elsevier Inc.

Entities:  

Keywords:  Histology; Liver biopsy; Steatohepatitis; Steatosis

Mesh:

Year:  2015        PMID: 26775559      PMCID: PMC4889547          DOI: 10.1016/j.metabol.2015.11.008

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  55 in total

1.  Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

Authors:  James E Nelson; Laura Wilson; Elizabeth M Brunt; Matthew M Yeh; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

2.  Cytokeratin of apparent high molecular weight in livers from griseofulvin-fed mice.

Authors:  M Cadrin; N Marceau; S W French
Journal:  J Hepatol       Date:  1992-03       Impact factor: 25.083

3.  Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years.

Authors:  Nicolas V Christou; Didier Look; Lloyd D Maclean
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

4.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

5.  Validation of the non-alcoholic fatty liver disease activity score.

Authors:  M Hjelkrem; C Stauch; J Shaw; S A Harrison
Journal:  Aliment Pharmacol Ther       Date:  2011-05-18       Impact factor: 8.171

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.

Authors:  Shahid M Malik; Michael E Devera; Paulo Fontes; Obaid Shaikh; Eizaburo Sasatomi; Jawad Ahmad
Journal:  Liver Transpl       Date:  2009-12       Impact factor: 5.799

8.  Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities.

Authors:  Myriam Moretto; Carlos Kupski; Cláudio Corá Mottin; Giuseppe Repetto; Marcelo Garcia Toneto; Jacqueline Rizzolli; Diovanne Berleze; Cesar Luis de Souza Brito; Daniela Casagrande; Fernanda Colossi
Journal:  Obes Surg       Date:  2003-08       Impact factor: 4.129

9.  Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients.

Authors:  H C Pinto; A Baptista; M E Camilo; A Valente; A Saragoça; M C de Moura
Journal:  Dig Dis Sci       Date:  1996-01       Impact factor: 3.199

10.  Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.

Authors:  Ariel E Feldstein; Anna Wieckowska; A Rocio Lopez; Yao-Chang Liu; Nizar N Zein; Arthur J McCullough
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

View more
  58 in total

1.  Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.

Authors:  Mohammad Nasser Kabbany; Praveen Kumar Conjeevaram Selvakumar; Kymberly Watt; Rocio Lopez; Zade Akras; Nizar Zein; William Carey; Naim Alkhouri
Journal:  Am J Gastroenterol       Date:  2017-02-14       Impact factor: 10.864

Review 2.  Preclinical models of non-alcoholic fatty liver disease.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Arun J Sanyal
Journal:  J Hepatol       Date:  2017-11-09       Impact factor: 25.083

3.  Exenatide Prevents Diet-induced Hepatocellular Injury in A CEACAM1-Dependent Mechanism.

Authors:  Hilda E Ghadieh; Harrison T Muturi; Sonia M Najjar
Journal:  J Diabetes Treat       Date:  2017-12-19

4.  Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.

Authors:  J Latorre; J M Moreno-Navarrete; J M Mercader; M Sabater; Ò Rovira; J Gironès; W Ricart; J M Fernández-Real; F J Ortega
Journal:  Int J Obes (Lond)       Date:  2017-01-25       Impact factor: 5.095

Review 5.  Obesity and cancer: inflammation bridges the two.

Authors:  Ryan Kolb; Fayyaz S Sutterwala; Weizhou Zhang
Journal:  Curr Opin Pharmacol       Date:  2016-07-16       Impact factor: 5.547

Review 6.  Nonalcoholic Fatty Liver Disease in Children: Not a Small Matter.

Authors:  Praveen Kumar Conjeevaram Selvakumar; Mohammad Nasser Kabbany; Naim Alkhouri
Journal:  Paediatr Drugs       Date:  2018-08       Impact factor: 3.022

7.  When the beverage is sweet, how does the liver feel?

Authors:  Dong Xi; Rohit Kohli
Journal:  Curr Treat Options Pediatr       Date:  2019-11-11

8.  Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease.

Authors:  Yuchang Li; Liting Chen; Lu Li; Chantal Sottas; Stephanie K Petrillo; Anthoula Lazaris; Peter Metrakos; Hangyu Wu; Yuji Ishida; Takeshi Saito; Lucy Golden-Mason; Hugo R Rosen; Jeremy J Wolff; Cristina I Silvescu; Samuel Garza; Garett Cheung; Tiffany Huang; Jinjiang Fan; Martine Culty; Bangyan Stiles; Kinji Asahina; Vassilios Papadopoulos
Journal:  iScience       Date:  2021-05-01

9.  Prospective assessment of liver stiffness by shear wave elastography in childhood obesity: a pilot study.

Authors:  Domenico Corica; Antonio Bottari; Tommaso Aversa; Letteria Anna Morabito; Selenia Curatola; Angela Alibrandi; Giorgio Ascenti; Malgorzata Wasniewska
Journal:  Endocrine       Date:  2021-07-23       Impact factor: 3.633

Review 10.  Excessively Enlarged Mitochondria in the Kidneys of Diabetic Nephropathy.

Authors:  Kiyoung Kim; Eun-Young Lee
Journal:  Antioxidants (Basel)       Date:  2021-05-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.